|
GLUD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.575700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.994240E-01 |
| Normal-vs-Stage2 |
4.158200E-01 |
| Normal-vs-Stage3 |
7.677000E-03 |
| Normal-vs-Stage4 |
1.695010E-03 |
| Stage1-vs-Stage2 |
9.939000E-01 |
| Stage1-vs-Stage3 |
3.170100E-02 |
| Stage1-vs-Stage4 |
4.018000E-02 |
| Stage2-vs-Stage3 |
1.339560E-01 |
| Stage2-vs-Stage4 |
7.390200E-02 |
| Stage3-vs-Stage4 |
5.798600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.934100E-02 |
| Normal-vs-AfricanAmerican |
1.417800E-01 |
| Normal-vs-Asian |
1.302790E-01 |
| Caucasian-vs-AfricanAmerican |
9.246800E-01 |
| Caucasian-vs-Asian |
5.954600E-01 |
| AfricanAmerican-vs-Asian |
5.616200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.623600E-02 |
| Normal-vs-Female |
2.199600E-01 |
| Male-vs-Female |
5.787600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.202900E-03 |
| Normal-vs-Extreme_Weight |
3.841600E-02 |
| Normal-vs-Obese |
1.926560E-01 |
| Normal-vs-Extreme_Obese |
8.442400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.610370E-01 |
| Normal_Weight-vs-Obese |
6.996400E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.372100E-02 |
| Extreme_Weight-vs-Obese |
5.338000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.131400E-01 |
| Obese-vs-Extreme_Obese |
4.014400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.394230E-02 |
| Normal-vs-Age(41-60Yrs) |
1.795150E-01 |
| Normal-vs-Age(61-80Yrs) |
9.174400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.52889999999384E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.452450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.011400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.523600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.361400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.81740000004815E-06 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.96239999999959E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.401800E-01 |
| Normal-VS-Type2 PRCC |
6.31719999999447E-05 |
| Normal-VS-KIRP CIMP |
3.69519970178089E-10 |
| Normal-VS-Unclassified PRCC |
5.155600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.06460000207187E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.62625468647093E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
1.171950E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.855510E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.102040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.444200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.503160E-01 |
| Normal-vs-N1 |
1.7510000005494E-07 |
| Normal-vs-N2 |
1.004210E-03 |
| N0-vs-N1 |
4.951800E-04 |
| N0-vs-N2 |
3.87769999999898E-05 |
| N1-vs-N2 |
2.784400E-01 |
|
|
